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cGMP is the common second messenger for the cardiovas-
cular effects of nitric oxide (NO) and natriuretic peptides,
such as ANP and BNP, which activate the soluble and par-
ticulate forms of guanylyl cyclase, respectively. However,
natriuretic peptides and NO donors exert distinct effects
on cardiac and vascular smooth muscle function. We
therefore tested whether these differences are due to an
intracellular compartmentation of cGMP and evaluated
the role of phosphodiesterase (PDE) subtypes in this
process.
Subsarcolemmal cGMP signals were monitored in adult
rat cardiomyocytes by expression of the rat olfactory cyclic
nucleotide-gated (CNG) channel α-subunit and recording
of the associated cGMP-gated current (ICNG).
Our main results indicate that: (1) the particulate cGMP
pool is readily accessible at the plasma membrane,
whereas the soluble pool is not; (2) PDE5 controls the sol-
uble but not the particulate pool, whereas the latter is
under the exclusive control of PDE2; (3) both pools are
oppositely regulated by cGMP-dependent protein kinase
(PKG), with PKG inhibiting the soluble pool (via PDE5
activation) and activating the particulate pool (in a PDE-
independent manner).
These differential spatiotemporal distributions and regu-
lations of cGMP signals may contribute to the specific
effects of natriuretic peptides and NO donors on cardiac
function.
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